Ridgemont Partners Management, LLC
Annual return '25
+10.3%
SPY '25
+17.7%
Alpha
-7.4ptsvs SPY
Invested
$2.1B
Holdings
29
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 98%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$ZYME
ZYMEWORKS INC
Held since at least Q1 2024
19.0%
02
$ANAB
ANAPTYSBIO INC
Held since at least Q1 2024
11.7%
03
$QURE
UNIQURE NV
Held since at least Q1 2024
11.3%
04
$JAZZ
JAZZ PHARMACEUTICALS PLC
Held since at least Q1 2024
10.9%
05
$CRNX
CRINETICS PHARMACEUTICALS IN
Held since at least Q1 2024
8.6%
06
$CRSP
CRISPR THERAPEUTICS AG
Held since at least Q1 2024
4.4%
07
$TNGX
TANGO THERAPEUTICS INC
Held since at least Q1 2024
4.3%
08
$ORIC
ORIC PHARMACEUTICALS INC
Held since at least Q1 2024
3.9%
09
$APLS
APELLIS PHARMACEUTICALS INC
Held since at least Q1 2024
3.8%
10
$XNCR
XENCOR INC
Held since at least Q1 2024
3.5%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 08:05 UTC.